Hyperinsulinaemia, regional adipose tissue distribution and left ventricular mass in normotensive, elderly, obese subjects

European Heart Journal

Volumn 19, Issue 2, 1998, Pages 326-331

  Vetta, F ^a   Cicconetti, P ^a   Ronzoni, S ^a   Rizzo, V ^a   Palleschi, L ^a   Canarile, G ^a   Lupattelli, M R ^a   Migliori, M ^a   Morelli, S ^a   Marigliano, V ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ageing; Ambulatory blood pressure; Hyperinsulinaemia; Left ventricular mass; Obesity

Indexed keywords

ADIPOSE TISSUE; ADULT; AGED; AGING; ANTHROPOMETRY; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; REGRESSION ANALYSIS; TISSUE DISTRIBUTION; ULTRASOUND;

ADIPOSE TISSUE; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BODY COMPOSITION; ECHOCARDIOGRAPHY; HEART VENTRICLES; HUMANS; HYPERINSULINISM; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; OBESITY; REFERENCE VALUES;

EID: 13144254190     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1997.0731     Document Type: Article

References (47)

1. Hubert HB, Feinleib M, McNamara PM, Castelli P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-77.
2. Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk factors and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation 1996; 7: 1372-9.
3. Tobian L. Hypertension and obesity. N Engl J Med 1978; 298: 46-8.
4. Ostlund RE Jr, Staten M, Kohrt WM et al. The ratio of waist to hip circumference, plasma insulin level and glucose intolerance as independent predictors of the HDL cholesterol level in older adults. N Engl J Med 1990; 322: 229-34.
5. De Fronzo RA, Ferranini E. Insulin resistance: a multifaced syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
6. Levy D, Garrison RJ, Savage DD et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med 1989; 110: 101-7.
7. Levy D, Garrison RJ, Savage DD et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Eng J Med 1990; 322: 1561-6.
8. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study. JAMA 1991; 266: 231-6.
9. Casale PN, Devereux RB, Milner M et al. Value of echocardiographic measurements of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-8.
10. Koren MJ, Devereux RB, Casale PN et al. Relation of Left Ventricular Mass and Geometry to morbidity and mortality in Uncomplicated Essential Hypertension. Ann Intern Med 1991; 114: 345-52.
11. Verdecchia P, Schillaci G, Borgioni C et al. Adverse prognostic significance of concentric remodeling of left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 1995; 25: 871-8.
12. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham heart study. J Am Coll Cardiol 1995; 25: 879-84.
13. Ganau A, Devereux RB, Casale PN et al Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension J Am Coll Cardiol 1992; 19: 1550-8.
14. Sasson Z, Rasooly Y, Bhesania T et al. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 1993; 88: 1431-6.
15. Høegholm A, Eidemak I, Kristensen KS, Bang LE, Madsen NH. Clinical evaluation of the Takeda Medical (A&D) TM 2420 ambulatory blood pressure monitor: practical experience and comparison with direct and indirect measurements. Scan J Clin Lab Invest 1992; 52: 261-8.
16. Mancia G, Di Rienzo M, Parati G et al. Ambulatory blood pressure monitoring use in hypertension research and clinical practice. Hypertension 1993; 21: 510-32.
17. Devereux RB, Reicheck N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613-18.
18. De Simone G, Daniels SR, Devereux RB et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20: 1251-60.
19. Reichek N, Devereux RB. Reliable estimation of peak left ventricular pressure by M-mode echocardiographic-determination end diastolic relative wall thickness: identification of severe valvular aortic stenosis in adult patients. Am Heart J 1982; 103: 202-9.
20. Armellini F, Zamboni M Rigo L et al. The contribution of sonography to the measurement of intra-abdominal fat. J Clin Ultrasound 1990; 18: 563-7.
21. Gillum RF. The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors in men and in women aged 18-79 years. J Chron Dis 1987; 40: 421-9.
22. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-57.
23. Richterich R, Dauwalder H. Zur bestimmung der plasmaglukosekonzentration mit der hexokinase-glucose-6-phosphatdehydrogenase-methode. Schweiz Med Wochenschr 1971; 101: 615-18.
24. Desbuquois B, Aurbach GD. Use of polyethylene glycol to separate free and antibody-bound to peptide hormones in radioimmuneassay. J Clin Endocrinol Metab 1971; 37: 732-8.
25. Haffner SM, Stern MP, Hazuda HP et al. Hyperinsulinemia in a population at high risk for NIDDM. N Eng J Med 1986; 315: 220-4.
26. Caro JF. Insulin resistance in obese and nonobese man. J Clin Endocrin Met 1991; 73: 691-5.
27. Hammond IW, Devereux RB, Alderman MH et al Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol 1988; 12: 996-1004.
28. Gardin MJ, Siscovck D, Anton-Culver H et al. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free living elderly. Circulation 1995; 91: 1739-48.
29. Messerli FH, Sundgaard-Riise K, Reisen ED et al. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med 1983; 99: 757-61.
30. Himeno E, Nishino K, Nakashima Y, Kuroiwa A, Ikeda M. Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects. Am Heart J 1996; 131: 313-19.
31. D'Ercole AJ, Underwood LE, Groelke J et al. Leprechaunism: studies of the relationship among hyperinsulinism, insulin resistance and growth retardation. J Clin Endocrinol Metab 1979; 48: 495-509.
32. Reuban K, Blizzard RM, Parker MA et al. Hypertrophic cardiomyopathy in total lipodystrophy. J Pediatr 1986; 109: 301-2.
33. Shenoy MM, Goldman JM. Hypothyroid cardiomyopathy: echocardiographic documentation of reversibility. Am J Med Sci 1987; 294: 1-9.
34. Smallridge RC, Rajfer S, Davia J et al. Acromegaly and the heart: an echocardiographic study. Am J Med 1979; 66: 22-7.
35. Breitweser JA, Meyer RA, Sperling MA et al. Cardiac septal hypertrophy in hyperinsulinemic infants. J Pediatr 1980; 96: 535-9.
36. Lind L, Andersson PE, Andren B, Hanni A, Lithell HO. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens 1995; 13: 433-8.
37. Ohya Y, Abe I, Fujii K et al. Hyperinsulinemia and left ventricular geometry in a work-site population in Japan. Hypertension 1996; 27: 729-34.
38. Straus DS. Growth-stimulatory actions of insulin in vitro and in vivo. Endocr Rev 1984; 5: 356-67.
39. Ito H, Hiroe M, Hirata Y et al. Insulin-like growth factor-I induces cardiac hypertrophy with enhanced expression of muscle-specific genes in cultured rat cardiomyocytes. Circulation 1993; 87: 1715-21.
40. Moolemar WH, Tsien RY, Saag PT et al. Na-H exchange and cytoplasmatic pH in the action of growth factors in human fibroblasts. Nature 1983; 304: 645-8.
41. Merban E, Koretsune Y. Cell calcium, oncogenes and hypertrophy. Hypertension 1990; 15: 332-7.
42. Halkin H, Modan M, Shefi M et al. Altered erythrocyte and plasma sodium and potassium in hypertension, a facet of hyperinsulinemia. Hypertension 1988; 11: 71-7.
43. Calderone A, Takahashi N, Izzo NJ, Thaik CM, Colucci WS. Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation 1995; 92: 2385-90.
44. Mahnensmith RL, Aronson PS. The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes. Cir Res 1985; 56: 773-88.
45. Landsberg L, Kreiger DR. Obesity, metabolism and the sympathetic nervous system. Am J Hypertens 1989; 2: 1255-1325.
46. Trevisan R, Fioretto P, Semplicini A et al. Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes 1990; 39: 289-98.
47. Messerli FH Cardiovascular effects of obesity and hypertension. Lancet 1982; 1: 1165-8.